Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticHematopoietic Stem CellsTransplantation ConditioningLeukemiaTransplantation ChimeraBone Marrow PurgingLiver TransplantationGraft SurvivalTissue DonorsBone Marrow DiseasesBusulfanHistocompatibility TestingStem CellsHistocompatibilityHematopoiesisCyclophosphamideBone Marrow ExaminationTransplantation, IsogeneicMice, Inbred C57BLBone Marrow NeoplasmsStem Cell TransplantationRadiation ChimeraKidney TransplantationRecurrenceCombined Modality TherapyLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsTreatment OutcomeHematologic NeoplasmsRemission InductionImmunosuppressive AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaColony-Forming Units AssayGraft RejectionLeukemia, MyeloidHepatic Veno-Occlusive DiseaseBone RemodelingT-LymphocytesTransplantation ImmunologyGraft vs Host ReactionLymphocyte DepletionImmunosuppressionLymphoma, Non-HodgkinAcute DiseaseLeukocyte TransfusionChimeraCell DifferentiationMyelodysplastic SyndromesHeart TransplantationSevere Combined ImmunodeficiencySurvival AnalysisHLA AntigensCells, CulturedRetrospective StudiesFlow CytometryHematologic DiseasesSpleenLeukocyte CountCyclosporineLymphocyte TransfusionPancytopeniaActuarial AnalysisLung TransplantationAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorBone DensityAntigens, CD34Nuclear FamilyCarmustineMice, Inbred BALB CFollow-Up StudiesCytarabineMultiple MyelomaSurvival RateGraft vs Tumor EffectOrgan TransplantationGraft vs Leukemia EffectCytomegalovirus InfectionsMelphalanGranulocytesMice, KnockoutCell SeparationBone ResorptionLymphomaImmunophenotypingDisease-Free SurvivalEtoposidePeripheral Blood Stem Cell TransplantationBlood CellsThymus Gland